<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">In addition, 41% of patients in this hospital in Chongqing developed drug-related hepatotoxicity caused by first-line drugs (INH, RFP, and pyrazinamide). This could affect patientsâ€™ adherence to treatment and increase the risk of DR-TB. There is an urgent need for more effective anti-TB drugs to shorten the treatment duration, for better healthcare accessibility (both location and capable laboratories), and for faster TB/DR-TB diagnosis to avoid clinical deterioration, death, and transmission [
 <xref ref-type="bibr" rid="CR42">42</xref>].
</p>
